BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ACVR1, SKR1, 90, ENSG00000115170, Q04771, ACVRLK2, FOP, ALK2, ACTRI AND Treatment
5126 results:

  • 1. Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.
    Chang GC; Shih JY; Yu CJ; Chao HS; Yang CT; Lin CC; Hung JY; Hsiao SY; Wang CC; Chian CF; Hsia TC; Chen YM
    PLoS One; 2024; 19(5):e0303046. PubMed ID: 38753697
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Aprospective study of detection and clinical significance of bone marrow tumor cells in small cell lung cancer].
    Wang Y; Lu BH; Gao Y; Liu YX; Hu MM; Che NY; Lin HF; Li HX; Zhang HM; Zhang TM
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):419-427. PubMed ID: 38742355
    [No Abstract]    [Full Text] [Related]  

  • 3. [Effect of peripheral blood inflammatory indicators on the efficacy of immunotherapy in patients with advanced non-small cell lung cancer and chronic obstructive pulmonary disease].
    Bi ZK; Xu Y; Guo L; Zhang WJ; You YT; Li JW; Zhao CL; Shan YF; Xia TT; Li YF; Xu Z; Fan Y; Bai L
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1601-1609. PubMed ID: 38742347
    [No Abstract]    [Full Text] [Related]  

  • 4. Blood Pressure, Readmission, and Mortality Among Patients Hospitalized With Acute Kidney Injury.
    Griffin BR; Vaughan-Sarrazin M; Shi Q; Ten Eyck P; Reisinger HS; Kennelty K; Good MK; Swee ML; Yamada M; Lund BC; Jalal DI
    JAMA Netw Open; 2024 May; 7(5):e2410824. PubMed ID: 38739389
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study.
    Ren S; Xiong A; Yu J; Wang X; Han B; Pan Y; Zhao J; Cheng Y; Hu S; Liu T; Li Y; Cheng Y; Feng J; Yi S; Gu S; Gao S; Luo Y; Liu Y; Liu C; Duan H; Wang S; Yang X; Fan J; Zhou C
    Cancer Immunol Immunother; 2024 May; 73(7):124. PubMed ID: 38727837
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
    J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Neoadjuvant immunotherapy improves outcomes for resectable gastroesophageal junction cancer: A systematic review and meta-analysis.
    Wu D; Yang L; Yan Y; Jiang Z; Liu Y; Dong P; Lv Y; Zhou S; Qiu Y; Yu X
    Cancer Med; 2024 May; 13(9):e7176. PubMed ID: 38716645
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [An investigation of the advantages of the adjustable angle stitch template compared with CT-guided
    Wang J; Hao L; Lei GY; Song YC; Niu HX
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):480-485. PubMed ID: 38715485
    [No Abstract]    [Full Text] [Related]  

  • 9. Engineering PD-1-targeted small protein variants for in vitro diagnostics and in vivo PET imaging.
    Mierzwicka JM; Petroková H; Kafková LR; Kosztyu P; Černý J; Kuchař M; Petřík M; Bendová K; Krasulová K; Groza Y; Vaňková L; Bharadwaj S; Panova N; Křupka M; Škarda J; Raška M; Malý P
    J Transl Med; 2024 May; 22(1):426. PubMed ID: 38711085
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Sci Rep; 2024 May; 14(1):10162. PubMed ID: 38702426
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Video-Assisted vs Robotic-Assisted lung Lobectomies for Operating Room Resource Utilization and Patient Outcomes.
    Tupper HI; Lawson BL; Kipnis P; Patel AR; Ashiku SK; Roubinian NH; Myers LC; Liu VX; Velotta JB
    JAMA Netw Open; 2024 May; 7(5):e248881. PubMed ID: 38700865
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The cost-effectiveness of iruplinalkib versus alectinib in anaplastic lymphoma kinase-positive crizotinib-resistant advanced non-small-cell lung cancer patients in China.
    Dai Z; Xu J; Chang F; Zhou W; Ren T; Qiu J; Lu Y; Lu Y
    Front Public Health; 2024; 12():1333487. PubMed ID: 38699428
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Comparative Analysis of Implant-sparing Plan
    Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
    In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeting KRAS in pancreatic cancer.
    Stickler S; Rath B; Hamilton G
    Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
    Viana Veloso GG; Amaral FD; Nogueira-Rodrigues A
    BMC Cancer; 2024 Apr; 24(1):539. PubMed ID: 38679710
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
    Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
    Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database.
    Sun R; Ning Z; Qin H; Zhang W; Teng Y; Jin C; Liu J; Wang A
    Sci Rep; 2024 Apr; 14(1):9552. PubMed ID: 38664423
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Quantum-enhanced hybrid feature engineering in thoracic CT image analysis for state-of-the-art nodule classification: an advanced lung cancer assessment.
    Shivwanshi RR; Nirala N
    Biomed Phys Eng Express; 2024 May; 10(4):. PubMed ID: 38663368
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell lung cancer.
    Mooradian MJ; Cai L; Wang A; Qiao Y; Chander P; Whitaker RM
    JAMA Netw Open; 2024 Apr; 7(4):e247542. PubMed ID: 38648057
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 257.